This study is looking at ways to reduce pain and the need for strong pain medications (narcotics) after a hysterectomy (surgery to remove the uterus). You might be eligible if you are a woman between 18 and 65 years old, planning a minimally invasive hysterectomy for a non-cancerous reason like fibroids or endometriosis. The study will compare three different treatments given directly into the abdomen (intraperitoneal) using a special pump for 72 hours after surgery: ropivacaine, a combination of ropivacaine and ketorolac (an anti-inflammatory drug), or a saline solution (placebo). Researchers will measure your pain levels at 1, 2, and 4 hours after surgery to see if these treatments are effective. The study aims to find out if these infusions can significantly lower your pain and narcotic use.

Study design

This is a prospective, double-blinded, placebo-controlled study involving 120 participants. Participants will be randomly assigned to one of three treatment groups.

What's involved

You will complete a health-related quality of life questionnaire before surgery. After surgery, you will receive an infusion for 72 hours, and your pain levels will be measured at 1, 2, and 4 hours post-operation.

Compensation

Not stated in the trial record.

Follow-up

Your pain levels will be measured at 1, 2, and 4 hours after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.